All In Biotech

Drug Trial Radar · NCT07044271

A Study of Multiple Olomorasib (LY3537982) Capsules in Healthy Participants

An Open-Label, Randomized, 3-Way Crossover Study Comparing the Pharmacokinetics of Multiple Olomorasib (LY3537982) Capsules

Last checked: Nov 19, 2026Latest source record: May 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 120 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

120

Actual

Start

Jul 11, 2025

Primary completion

Nov 8, 2025

Study completion Nov 8, 2025

Sponsor

Lead sponsor
Eli Lilly and CompanyEli Lilly (LLY)
Sponsor type
Industry
First posted
Jun 29, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Crossover
Masking
None
Primary purpose
Basic science
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 55 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The main purpose of this study is to measure how much olomorasib gets into the bloodstream and how long it takes the body to get rid of it. Healthy participants will take olomorasib by mouth. The study will last about 7 weeks and will include 10 back-to-back overnight stays in the research center.

Conditions

  • Healthy

Interventions

  • OlomorasibDrug

    Single dose

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Pharmacokinetics (PK): Area Under the Concentration versus Time Curve from Time Zero to Time t (AUC[0-tlast]) of OlomorasibTime frame: From Day 1, Predose up to 72 hours Postdose
  2. PK: Area Under the Concentration versus Time Curve from Zero to Infinity (AUC[0-∞]) of OlomorasibTime frame: From Day 1, Predose up to 72 hours Postdose
  3. PK: Maximum Observed Drug Concentration (Cmax) of OlomorasibTime frame: From Day 1, Predose up to 72 hours Postdose

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • ICON Early Phase Services

    San Antonio, Texas

  • ICON

    Salt Lake City, Utah

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.